191 related articles for article (PubMed ID: 37708056)
1. Metabolomic and Lipidomic Characterization of Meningioma Grades Using LC-HRMS and Machine Learning.
Safari Yazd H; Bazargani SF; Fitzpatrick G; Yost RA; Kresak J; Garrett TJ
J Am Soc Mass Spectrom; 2023 Oct; 34(10):2187-2198. PubMed ID: 37708056
[TBL] [Abstract][Full Text] [Related]
2. Radiomics and machine learning may accurately predict the grade and histological subtype in meningiomas using conventional and diffusion tensor imaging.
Park YW; Oh J; You SC; Han K; Ahn SS; Choi YS; Chang JH; Kim SH; Lee SK
Eur Radiol; 2019 Aug; 29(8):4068-4076. PubMed ID: 30443758
[TBL] [Abstract][Full Text] [Related]
3. Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling.
Monleón D; Morales JM; Gonzalez-Darder J; Talamantes F; Cortés O; Gil-Benso R; López-Ginés C; Cerdá-Nicolás M; Celda B
J Proteome Res; 2008 Jul; 7(7):2882-8. PubMed ID: 18507434
[TBL] [Abstract][Full Text] [Related]
4. Differential Plasma Metabolites between High- and Low-Grade Meningioma Cases.
Kurokawa GA; Hamamoto Filho PT; Delafiori J; Galvani AF; de Oliveira AN; Dias-Audibert FL; Catharino RR; Pardini MIMC; Zanini MA; Lima EO; Ferrasi AC
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613836
[TBL] [Abstract][Full Text] [Related]
5. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
[TBL] [Abstract][Full Text] [Related]
6. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW
J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430
[TBL] [Abstract][Full Text] [Related]
7. Genomic analysis of synchronous intracranial meningiomas with different histological grades.
Chowdhury T; Yoo Y; Seo Y; Dho YS; Kim S; Choi A; Choi M; Park SH; Park CK; Lee SH; Lee JY
J Neurooncol; 2018 May; 138(1):41-48. PubMed ID: 29423538
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic Profile of Aggressive Meningiomas by Using High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance.
Bender L; Somme F; Ruhland E; Cicek AE; Bund C; Namer IJ
J Proteome Res; 2020 Jan; 19(1):292-299. PubMed ID: 31679342
[TBL] [Abstract][Full Text] [Related]
9. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas.
Trinkaus M; Vranic A; Dolenc VV; Lah TT
Int J Biol Markers; 2005; 20(1):50-9. PubMed ID: 15832773
[TBL] [Abstract][Full Text] [Related]
10. Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs.
Ludwig N; Kim YJ; Mueller SC; Backes C; Werner TV; Galata V; Sartorius E; Bohle RM; Keller A; Meese E
Neuro Oncol; 2015 Sep; 17(9):1250-60. PubMed ID: 25681310
[TBL] [Abstract][Full Text] [Related]
11. Role of MR Morphology and Diffusion-Weighted Imaging in the Evaluation of Meningiomas: Radio-Pathologic Correlation.
Ranabhat K; Bishokarma S; Agrawal P; Shrestha P; Panth R; Ghimire RK
JNMA J Nepal Med Assoc; 2019; 57(215):37-44. PubMed ID: 31080244
[TBL] [Abstract][Full Text] [Related]
12. Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma.
Bruna J; Brell M; Ferrer I; Gimenez-Bonafe P; Tortosa A
Neuropathology; 2007 Apr; 27(2):114-20. PubMed ID: 17494511
[TBL] [Abstract][Full Text] [Related]
13. [Meningiomas: new prognostic factors].
Sanz Esponera J
An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
[TBL] [Abstract][Full Text] [Related]
14. Comparative proteomic profiles of meningioma subtypes.
Okamoto H; Li J; Vortmeyer AO; Jaffe H; Lee YS; Gläsker S; Sohn TS; Zeng W; Ikejiri B; Proescholdt MA; Mayer C; Weil RJ; Oldfield EH; Zhuang Z
Cancer Res; 2006 Oct; 66(20):10199-204. PubMed ID: 17047085
[TBL] [Abstract][Full Text] [Related]
15. Spinal Versus Intracranial Meningioma: Aberrant Expression of CD10 and Inhibin with Relation to Clinicopathological Features and Prognosis.
Foda AAM; Rafi S; Ikram N; Alam MS; Ayesha S
Pathol Oncol Res; 2020 Apr; 26(2):1313-1318. PubMed ID: 31372897
[TBL] [Abstract][Full Text] [Related]
16. Anaplastic meningioma: progression from atypical and chordoid morphotype with morphologic spectral variation at recurrence.
Bollag RJ; Vender JR; Sharma S
Neuropathology; 2010 Jun; 30(3):279-87. PubMed ID: 19780983
[TBL] [Abstract][Full Text] [Related]
17. [Multiple intracranial and intraspinal meningiomas successively discovered in the absence of neurofibromatosis: 2 cases].
Drouet A; Guilloton L; Pelissou-Guyotat I; Saint-Pierre G; Ribot C; Sindou M; Deruty R
Rev Neurol (Paris); 2001 Oct; 157(10):1264-9. PubMed ID: 11885519
[TBL] [Abstract][Full Text] [Related]
18. World Health Organization Grade III Meningiomas: A Retrospective Study at an Academic Medical Center.
Sá-Marta E; Alves JL; Rebelo O; Barbosa M
World Neurosurg; 2021 May; 149():e877-e893. PubMed ID: 33516862
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathogenesis of meningiomas.
Perry A; Gutmann DH; Reifenberger G
J Neurooncol; 2004 Nov; 70(2):183-202. PubMed ID: 15674477
[TBL] [Abstract][Full Text] [Related]
20. A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.
Ferraro DJ; Funk RK; Blackett JW; Ju MR; DeWees TA; Chicoine MR; Dowling JL; Rich KM; Drzymala RE; Zoberi I; Simpson JR; Jaboin JJ
Radiat Oncol; 2014 Jan; 9():38. PubMed ID: 24467972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
